Delivery Order SPE2DE24D0013-SPE2D626F130F
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $4,320 on November 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated 4569923600 XPCOV2/FLU/RSV-10, is scheduled for completion by November 13, 2025, and represents procurement of diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The contract carries no set-aside designation,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,104 on September 11, 2025, with an ultimate completion date of September 18, 2025. The contract, designated XPRSTREPA-10, was issued by the Medical Supply Chain division of the Defense Logistics Agency with no set-aside designation. The place of performance is Sunnyvale, California, and the low contract value suggests this represents a specific...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,259.80 by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued under contract number GXGBSLBXC-10, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F130FDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside designation and reflects Cepheid's established position as a primary federal supplier of GeneXpert diagnostic platform reagents and test kits for infectious disease detection across multiple federal healthcare agencies. This delivery order is part of a larger pattern of procurement activity reflecting the federal government's reliance on Cepheid's diagnostic capabilities. The company holds multiple Indefinite Delivery Contracts with the Department of Veterans Affairs, including a $32.8 million contract with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 extending through December 2029, which have generated numerous delivery orders for diagnostic testing system reagents and assays. The current Medical Supply Chain delivery order continues this demand-driven procurement model, supporting federal healthcare operations' molecular diagnostic testing requirements for conditions including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/12/25 |